RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
18.58B
Enterprise Value 3
19.75B
Trailing P/E
46.15
Forward P/E 1
29.57
PEG Ratio (5 yr expected) 1
2.29
Price/Sales (ttm)
7.13
Price/Book (mrq)
8.96
Enterprise Value/Revenue 3
7.58
Enterprise Value/EBITDA 6
25.10

Trading Information

Stock Price History

Beta (3Y Monthly) 0.24
52-Week Change 322.31%
S&P500 52-Week Change 35.71%
52 Week High 3141.25
52 Week Low 390.64
50-Day Moving Average 3134.32
200-Day Moving Average 3121.38

Share Statistics

Avg Vol (3 month) 3516.11k
Avg Vol (10 day) 3407.85k
Shares Outstanding 5143.67M
Float 142.38M
% Held by Insiders 11.21%
% Held by Institutions 171.01%
Shares Short (Sep 30, 2019) 41.91M
Short Ratio (Sep 30, 2019) 43.49
Short % of Float (Sep 30, 2019) 41.49%
Short % of Shares Outstanding (Sep 30, 2019) 41.33%
Shares Short (prior month Aug 30, 2019) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 41.56
Forward Annual Dividend Yield 41.20%
Trailing Annual Dividend Rate 31.50
Trailing Annual Dividend Yield 31.16%
5 Year Average Dividend Yield 41.69
Payout Ratio 452.86%
Dividend Date 3Sep 19, 2019
Ex-Dividend Date 4Aug 14, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Aug 31, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 15.52%
Operating Margin (ttm)24.40%

Management Effectiveness

Return on Assets (ttm)11.08%
Return on Equity (ttm)19.59%

Income Statement

Revenue (ttm)2.61B
Revenue Per Share (ttm)18.21
Quarterly Revenue Growth (yoy)13.00%
Gross Profit (ttm)1.54B
EBITDA 786.78M
Net Income Avi to Common (ttm)404.59M
Diluted EPS (ttm)2.80
Quarterly Earnings Growth (yoy)-37.30%

Balance Sheet

Total Cash (mrq)147.13M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)1.27B
Total Debt/Equity (mrq)61.33
Current Ratio (mrq)2.06
Book Value Per Share (mrq)14.43

Cash Flow Statement

Operating Cash Flow (ttm)459.05M
Levered Free Cash Flow (ttm)423.41M